+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

UV Infection Control Devices Market by Type, End User: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 5031427
  • Report
  • March 2020
  • Region: Global
  • 154 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Apollo Pharmac
  • CVS Health Corporation
  • DocMorris
  • Giant Eagle Inc.
  • Optum Rx Inc.
  • Rowlands Pharmacy
The global UV infection control devices market was valued at $317.42 million in 2018, and is projected to reach $524.84 million by 2026, registering a CAGR of 6.5% from 2019 to 2026.



The UV infection control device is one of the disinfectant systems that use ultraviolet rays to kill microorganism present in the various healthcare setting such as hospitals, clinics, ambulatory surgical centers, research center, emergency departments, and others. As health care-associated infections (HAIs) is rising every year, which are caused by microorganisms such as fungi, bacteria, viruses, and parasites that can affect patients seriously. The UV infection control device works base on UV light that reflects off walls and other surfaces and is absorbed by bacteria, whose light-sensitive porphyrin molecules become excited and, as a result, experience oxidative damage and cell death.

The major factor that contributes to the growth of UV infection control device market include increase in government focus on infection control programs and an increase in the The prevalence of hospital acquired infections (HAI). Furthermore, other factors that boost UV infection control device market growth include rising adoption of technologically advanced UV equipment. However, the high cost of UV infection control devices and stringent government regulations hampers the growth of UV infection control devices market. Conversely, high growth potential in developing economies is expected to offer lucrative opportunities during the forecast period.

The UV infection control devices market size is studied on the basis of type, end users, and region. By type, the market is bifurcated into mobile, stationary, and other types. By end user, the market is segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Russia, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
  • This report entails a detailed quantitative analysis along with the current global UV infection control devices market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessments.
  • The market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments

By Type
  • Mobile
  • Stationary
  • Other types

By End User
  • Hospitals
  • Clinics
  • Others

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

List of key players profiled in the report:
  • CVS Health Corporation
  • DocMorris
  • Express Scripts Holding Company
  • Giant Eagle Inc.
  • Optum Rx Inc.
  • Rowlands Pharmacy
  • The Kroger Co.
  • Walgreen Co.
  • Walmart Stores Inc.
  • Apollo Pharmacy

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
  • The Miele Group
  • Melag Medizintechnik OHG
Frequently Asked Questions about the Global UV Infection Control Devices Market

What is the estimated value of the Global UV Infection Control Devices Market?

The Global UV Infection Control Devices Market was estimated to be valued at $317.4 million in 2018.

What is the growth rate of the Global UV Infection Control Devices Market?

The growth rate of the Global UV Infection Control Devices Market is 6.5%, with an estimated value of $524.8 million by 2026.

What is the forecasted size of the Global UV Infection Control Devices Market?

The Global UV Infection Control Devices Market is estimated to be worth $524.8 million by 2026.

Who are the key companies in the Global UV Infection Control Devices Market?

Key companies in the Global UV Infection Control Devices Market include CVS Health Corporation, DocMorris, Express Scripts Holding Company, Giant Eagle Inc., Optum Rx Inc., Rowlands Pharmacy, The Kroger Co., Walgreen Co. and Apollo Pharmac.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Apollo Pharmac
  • CVS Health Corporation
  • DocMorris
  • Giant Eagle Inc.
  • Optum Rx Inc.
  • Rowlands Pharmacy

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top player positioning, 2018
3.3. Porter's five force analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in government focus on infection control programs
3.4.1.2. Increase in the The prevalence of hospital acquired infections (HAI)
3.4.1.3. Rising adoption of technologically advanced UV equipment
3.4.2. Restraints
3.4.2.1. High cost of UV infection control devices
3.4.2.2. Stringent government regulations
3.4.3. Opportunity
3.4.3.1. High growth prospects in emerging markets
CHAPTER 4: UV INFECTION CONTROL DEVICES MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Mobile Type
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Station Type
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Other Types
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: GLOBAL UV INFECTION CONTROL DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Clinics
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
CHAPTER 6: UV INFECTION CONTROL DEVICES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America UV infection control devices market, by country
6.2.2.1. U. S. UV infection control devices market, by type
6.2.2.2. U. S. UV infection control devices market, by end user
6.2.2.3. Canada UV infection control devices market, by type
6.2.2.4. Canada UV infection control devices market, by end user
6.2.2.5. Mexico UV infection control devices market, by type
6.2.2.6. Mexico UV infection control devices market, by end user
6.2.3. North America market size and forecast, by type
6.2.4. North America market size and forecast, by end user
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe UV infection control devices market, by country
6.3.2.1. Germany UV infection control devices market, by type
6.3.2.2. Germany UV infection control devices market, by end user
6.3.2.3. France UV infection control devices market, by type
6.3.2.4. France UV infection control devices market, by end user
6.3.2.5. UK UV infection control devices market, by type
6.3.2.6. UK UV infection control devices market, by end user
6.3.2.7. Italy UV infection control devices market, by type
6.3.2.8. Italy UV infection control devices market, by end user
6.3.2.9. Russia UV infection control devices market, by type
6.3.2.10. Russia UV infection control devices market, by end user
6.3.2.11. Rest of Europe UV infection control devices market, by type
6.3.2.12. Rest of Europe UV infection control devices market, by end user
6.3.3. Europe market size and forecast, by type
6.3.4. Europe market size and forecast, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific UV infection control devices market, by country
6.4.2.1. Japan UV infection control devices market, by type
6.4.2.2. Japan UV infection control devices market, by end user
6.4.2.3. China UV infection control devices market, by type
6.4.2.4. China UV infection control devices market, by end user
6.4.2.5. India UV infection control devices market, by type
6.4.2.6. India UV infection control devices market, by end user
6.4.2.7. Rest of Asia-Pacific UV infection control devices market, by type
6.4.2.8. Rest of Asia-Pacific UV infection control devices market, by end user
6.4.3. Asia-Pacific market size and forecast, by type
6.4.4. Asia-Pacific market size and forecast, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA UV infection control devices market, by country
6.5.2.1. Brazil UV infection control devices market, by type
6.5.2.2. Brazil UV infection control devices market, by end user
6.5.2.3. Saudi Arabia UV infection control devices market, by type
6.5.2.4. Saudi Arabia UV infection control devices market, by end user
6.5.2.5. South Africa UV infection control devices market, by type
6.5.2.6. South Africa UV infection control devices market, by end user
6.5.2.7. Rest of LAMEA UV infection control devices market, by type
6.5.2.8. Rest of LAMEA UV infection control devices market, by end user
6.5.3. LAMEA market size and forecast, by type
6.5.4. LAMEA market size and forecast, by end user
CHAPTER 7: COMPANY PROFILES
7.1. American Air & Water, Inc.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.2. American Ultraviolet
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.3. Lumalier Corp
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.4. Nikkiso Co. , Ltd.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. PDI, Inc.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.1. Key strategic moves and developments
7.6. Seal Shield, LLC
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.7. STERIS plc.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. THE CLOROX COMPANY
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. UVC Cleaning Systems
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.10. XENEX
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Key strategic moves and developments
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Apollo Pharmac
  • CVS Health Corporation
  • DocMorris
  • Giant Eagle Inc.
  • Optum Rx Inc.
  • Rowlands Pharmacy
According to this report titled, 'UV Infection Control Devices Market by Type, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2026,' the global UV infection control devices market size was valued at $317 million in 2018, and is projected to reach $525 million by 2026, registering a CAGR of 6.5% from 2019 to 2026.

UV infection control devices emit ultraviolet rays that can kill infection causing microorganisms present in various healthcare facilities such as hospitals, clinics, and others. Furthermore, there are different types of UV infection control devices available in the market. For instance, mobile UV infection control devices are portable and can be moved from one place to another easily. In addition, the devices have h andles all around which aid in the movement of device from one location to another. However, station type UV infection control devices are designed to plug into a st andard power outlet. Moreover, these devices work by reflecting UV light off the walls. This reflected light is then absorbed by bacteria, whose light-sensitive porphyrin molecules become excited and, as a result, experience oxidative damage and cell death.

Surge in government focus on infection control programs and an increase in the The prevalence of hospital acquired infections (HAI) are the major factors that contribute to the growth of the UV infection control devices market. Furthermore, a rise in the adoption of technologically advanced UV equipment further supplement the growth of the market. However, high cost of UV infection control devices and stringent government regulations hinder the growth of the market globally. On the contrary, high growth prospects in emerging markets can provide newer opportunities for the UV infection control devices market growth.

The global UV infection control devices market is segmented on the basis of type, end users, and region. By type, the market is bifurcated into mobile, stationary, and other types. By end user, the market is segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Russia, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).

By type, the mobile type segment holds the dominant position in 2018 and would continue to maintain the lead over the forecast period. This is attributed to its mobility; as the device is light and can be moved to different settings. In addition, the cost of mobile UV infection control devices is less expensive than the stationary IV infection control devices. Furthermore, these mobile units are specifically designed for the ease of use and elimination of human error. For instance, mobile UV infection devices are available with casters or with a h andcarts for maximum mobility. Therefore, the factors aforementioned contribute to the growth of the market.

By end user, the hospital segment occupied the largest share of the UV infection control devices market in 2018 owing to factors such as a rise in the number of UV infection control devices are used in the medical devices due to surge in cases of hospital acquired infections. In addition, surge in number of hospitals worldwide is further supporting the market growth. Hospital segment is also the fastest growing end user segment in UV infection control devices market.

North America accounted for the major UV infection control devices market share in 2018 and is expected to continue this trend, owing to presence of well-established healthcare infrastructure, higher buying power, and high adoption of advanced medical equipment. In addition, rise in cases of hospital acquired infection (HAIs) is another major factor that boost the growth of the market. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period attributed to the highly populated countries, with China being the first and India the second most populated countries. Therefore, the region has the potential to offer a huge patient base which is expected to boost the growth of the Asia-Pacific UV infection control devices market.

Key Findings of the Study:

By type, the mobile device segment occupied around half share of the global UV infection control devices market in 2018.
By end user, the hospitals segment is anticipated to grow with the highest CAGR throughout the forecast period.
By type, the others segment accounted for more than two-fifths share of the market in 2018.
BY region, Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
Note: Product cover images may vary from those shown
  • CVS Health Corporation
  • DocMorris
  • Express Scripts Holding Company
  • Giant Eagle Inc.
  • Optum Rx Inc.
  • Rowlands Pharmacy
  • The Kroger Co.
  • Walgreen Co.
  • Walmart Stores Inc.
  • Apollo Pharmac
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...